New Drug Approved for Food Allergies
The FDA has recently given its approval for Xolair, a novel medication designed to lower the risk of severe reactions in both children and adults who accidentally come into contact with trace amounts of common food allergens such as peanuts, tree nuts, milk, and dairy.
The groundbreaking development is set to significantly enhance the quality of life for individuals who constantly grapple with these risks. Xolair provides an added layer of protection for individuals prone to life-threatening reactions to everyday foods, and particularly for those allergic to multiple foods.
Many Canadians live with multiple chronic medical conditions, which can include food allergies. The new drug offers them an added layer of protection and potentially improves their quality of life. Managing chronic conditions often requires a comprehensive approach to healthcare, including prevention and management of potential triggers like food allergens. The availability of Xolair could be an important tool in this broader management strategy for those with food allergies.
Roni Caryn Rabin’s "What to Know About Xolair and Food Allergies" was published in The New York Times on February 25, 2024. Read the full New York Times article here, to learn more about Xolair, including the drug's significant stipulations.
Denied your long term disability claim?
Contact a disability lawyer at Share Lawyers today and put our experience to work for you. Our 35+ years of experience can help you win your case against Canada Life, Desjardins, Manulife, RBC Insurance, Sun Life, and other insurance companies. Our legal team offers a free consultation and there are no fees unless you win your case.
